Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study

  • Vanessa W. Stevens
  • , Cary Thurm
  • , Elyse M. Schwab
  • , Matthew P. Kronman
  • , Jeffrey S. Gerber
  • , Samir S. Shah
  • , Jason G. Newland
  • , Joshua Courter
  • , Sarah Parker
  • , Thomas V. Brogan
  • , Adam L. Hersh

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Concomitant antibiotic use during treatment for Clostridium difficile infection (CDI) increases the risk of recurrence. Across a network of children’s hospitals, 46% of patients treated for CDI received concomitant antibiotics for a median of 7 days. Concomitant antibiotic use was more common among patients with malignancies, and solid organ or bone marrow transplant. Unnecessary concomitant antibiotic use in CDI patients is a potential target for pediatric antimicrobial stewardship.

Original languageEnglish
Pages (from-to)45-51
Number of pages7
JournalInfectious Diseases and Therapy
Volume5
Issue number1
DOIs
StatePublished - Mar 1 2016

Keywords

  • Clostridium difficile infection
  • Concomitant antibiotics
  • Pediatric

Fingerprint

Dive into the research topics of 'Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study'. Together they form a unique fingerprint.

Cite this